Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati

Diabetic nephropathy is the most common cause of renal failure. The mortality rate from all causes in diabetic patients with nephropathy is 20-40 times higher than that of patients without nephropathy. In this study, the drug utilization profile on type 2 diabetic patient with nephr...

Full description

Saved in:
Bibliographic Details
Main Author: Felicita Hindarto, 050112440
Format: Theses and Dissertations NonPeerReviewed
Language:English
Indonesian
Published: 2005
Subjects:
Online Access:http://repository.unair.ac.id/45744/1/050112440.pdf
http://repository.unair.ac.id/45744/8/050112440.pdf
http://repository.unair.ac.id/45744/
http://ff.unair.ac.id
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
Indonesian
id id-langga.45744
record_format dspace
spelling id-langga.457442016-12-12T19:11:56Z http://repository.unair.ac.id/45744/ Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati Felicita Hindarto, 050112440 RC31-1245 Internal medicine RM300-666 Drugs and their actions Diabetic nephropathy is the most common cause of renal failure. The mortality rate from all causes in diabetic patients with nephropathy is 20-40 times higher than that of patients without nephropathy. In this study, the drug utilization profile on type 2 diabetic patient with nephropathy was analyzed descriptively used patient’s medical records by retrospective method. The results showed that patients with type 2 diabetic nephropathy use either ACEIs,CCBs, ARBs, ACEI and diuretic, ACEI and CCB as their antihypertensive therapy; insulin to control blood glucose intensively; the third generation cephalosporins antibiotics for urinary tract infection therapy; sodium bicarbonat, calsium carbonat or calsium gluconas for therapy of body electrolite imbalance; aspirin and dipiridamol as antiplatelet/haemoreology agents; H2 receptor antagonist as stress ulcer therapy; Packed Red Cell/PRC tranfusion as anemia therapy; allopurinol as hyperuricemia therapy; etc. Drug therapy of type 2 diabetic patient with nephropathy is quite complicated because it depends on the clinical presentation of patient. Diabetic nephropathy needs some potential therapeutic strategies primarily in the treatment proteinuria with the ACEI and/or ARBs, intensive blood pressure control, and intensive blood glucose control to prevent the proteinuria progression and the renal function’s decline. Further study is needed to learn more (dose, adverse drugs reaction, etc) about drug utilization of type 2 diabetic patient with nephropathy 2005 Thesis NonPeerReviewed text en http://repository.unair.ac.id/45744/1/050112440.pdf text id http://repository.unair.ac.id/45744/8/050112440.pdf Felicita Hindarto, 050112440 (2005) Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati. Skripsi thesis, UNIVERSITAS AIRLANGGA. http://ff.unair.ac.id
institution Universitas Airlangga
building Universitas Airlangga Library
country Indonesia
collection UNAIR Repository
language English
Indonesian
topic RC31-1245 Internal medicine
RM300-666 Drugs and their actions
spellingShingle RC31-1245 Internal medicine
RM300-666 Drugs and their actions
Felicita Hindarto, 050112440
Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
description Diabetic nephropathy is the most common cause of renal failure. The mortality rate from all causes in diabetic patients with nephropathy is 20-40 times higher than that of patients without nephropathy. In this study, the drug utilization profile on type 2 diabetic patient with nephropathy was analyzed descriptively used patient’s medical records by retrospective method. The results showed that patients with type 2 diabetic nephropathy use either ACEIs,CCBs, ARBs, ACEI and diuretic, ACEI and CCB as their antihypertensive therapy; insulin to control blood glucose intensively; the third generation cephalosporins antibiotics for urinary tract infection therapy; sodium bicarbonat, calsium carbonat or calsium gluconas for therapy of body electrolite imbalance; aspirin and dipiridamol as antiplatelet/haemoreology agents; H2 receptor antagonist as stress ulcer therapy; Packed Red Cell/PRC tranfusion as anemia therapy; allopurinol as hyperuricemia therapy; etc. Drug therapy of type 2 diabetic patient with nephropathy is quite complicated because it depends on the clinical presentation of patient. Diabetic nephropathy needs some potential therapeutic strategies primarily in the treatment proteinuria with the ACEI and/or ARBs, intensive blood pressure control, and intensive blood glucose control to prevent the proteinuria progression and the renal function’s decline. Further study is needed to learn more (dose, adverse drugs reaction, etc) about drug utilization of type 2 diabetic patient with nephropathy
format Theses and Dissertations
NonPeerReviewed
author Felicita Hindarto, 050112440
author_facet Felicita Hindarto, 050112440
author_sort Felicita Hindarto, 050112440
title Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
title_short Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
title_full Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
title_fullStr Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
title_full_unstemmed Studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
title_sort studi penggunaan obat pada penderita diabetes mellitus tipe 2 dengan komplikasi nefropati
publishDate 2005
url http://repository.unair.ac.id/45744/1/050112440.pdf
http://repository.unair.ac.id/45744/8/050112440.pdf
http://repository.unair.ac.id/45744/
http://ff.unair.ac.id
_version_ 1681145512714043392